Shopping Cart
- Remove All
- Your shopping cart is currently empty
S19-1035 is a potent and specific inhibitor of aldo-keto reductase 1C3 (AKR1C3), displaying an inhibitory concentration (IC50) of 3.04 nM. It is primarily utilized in tumor research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $33 | In Stock | |
10 mg | $50 | In Stock | |
25 mg | $103 | In Stock | |
50 mg | $167 | In Stock | |
100 mg | $271 | In Stock | |
200 mg | $398 | In Stock | |
1 mL x 10 mM (in DMSO) | $37 | In Stock |
Description | S19-1035 is a potent and specific inhibitor of aldo-keto reductase 1C3 (AKR1C3), displaying an inhibitory concentration (IC50) of 3.04 nM. It is primarily utilized in tumor research. |
Targets&IC50 | AKR1C3:3.04 nM |
In vitro | S19-1035 demonstrates low cytotoxicity (0-100 μM ; 72 h or 96 h) and limited antitumor efficacy when used alone.[1] S19-1035 significantly reverses the resistance of doxorubicin-resistant breast cancer cell lines when administered at 10 μM for 8 days.[1] |
In vivo | Setrobuvir (200, 400, and 800 mg) BID were -2.1, -2.2, and -2.9 log10 IU/mL, respectively (vs ≤0.1 log10 IU/mL with placebo).[3] |
Molecular Weight | 356.80 |
Formula | C19H17ClN2O3 |
Smiles | Cc1noc(C)c1COc1ccccc1C(=O)Nc1ccccc1Cl |
Relative Density. | no data available |
Storage | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 112.5 mg/mL (315.3 mM), Sonication and heating to 60℃ are recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.